Synthesis and antitumor activity of alpha-and beta-2'-deoxy-6-selenoguanosine and certain related derivatives.
D000818:Animals; D000963:Antimetabolites / Q000138:chemical synthesis* / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D003849:Deoxyguanosine / Q000031:analogs & derivatives; D003853:Deoxyribonucleosides / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D005246:Feedback; D006151:Guanosine / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D011687:Purines / Q000096:biosynthesis; D012643:Selenium / Q000494:pharmacology / Q000627:therapeutic use*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000963:Antimetabolites; D000970:Antineoplastic Agents; D003853:Deoxyribonucleosides; D011687:Purines; D006151:Guanosine; C007264:6-seleno-2'-deoxyguanosine; D003849:Deoxyguanosine; D012643:Selenium